The X-spine Silex Sacroiliac Joint Fusion System consists of two unique diameter cannulated implants offered in various lengths, in full and partially threaded configurations to accommodate variations in patient anatomy. It is intended for sacroiliac joint fusion for conditions including degenerative sacroiliitis and sacroiliac joint disruptions.
Features:
- Two unique diameter cannulated implants offered in various lengths
- Full and partially threaded configurations to accommodate variations in patient anatomy
- Titanium plasma-coated to aid in frictional resistance and provide bioactive template
Benefits:
- Silex™ system allows for fusion and stabilization of the SI joint in eligible patients whom appropriate non-surgical treatment has failed. The device can be placed through a small incision, and incorporates a proprietary dual-pitch compression-thread design and titanium plasma coating to stabilize the SI joint in fusion procedures.
- The design of the implant allows for bone graft to be introduced into the joint and implant in order to achieve a solid fusion.
- Unlike some recently-introduced SI arthroplasty-type systems which are not compatible with direct bone grafting of the SI joint space, the Silex™ is a true bony fusion and arthrodesis system. The implant and instrumentation suite allows for direct exposure and preparation of the SI joint surface, placement of bone graft into the SI joint space under direct visualization, and placement of bone graft directly within the Silex™ implant itself.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant’s people are dedicated and talented, operating with the highest integrity to serve our customers.
About Sacroiliac joint fusion technique
Sacroiliac joint dysfunction is responsible for 25% of lower back pain cases across the world. This is generally used to treat back or leg pain caused by SI joint dysfunction. Within the past few years, there has been resurgence in the recognition of the SI joint as a potential source of low back pain as treatment options for SI joint dysfunction have advanced.Numerous techniques exist for the surgical treatment of sacroiliac joint dysfunction. The main goal is to stabilize the joint by using implants and sometimes instrumentation.